ScreenerHero vs Stockopedia
Stockopedia charges €80/month
for US + Europe. We charge once.
Stockopedia's US + European plan costs €80/month — and doesn't include Canada. ScreenerHero covers US, Canada, Europe & Australia, including microcaps, with a one-time paid plan instead of a subscription. With a free tier that requires no account.
Stockopedia US+EU
€80/mo
ScreenerHero Lifetime
97€ once · no subscription
Updated October 2026 · Honest comparison, including where Stockopedia is genuinely better
After about 2 months, Stockopedia US+EU has cost you more than ScreenerHero Lifetime (97€, once).
Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.
Which is better, ScreenerHero or Stockopedia?
It depends on whether you want scores or raw filters. Stockopedia gives a score-driven workflow (StockRanks) with editorial context, on a monthly subscription. ScreenerHero gives raw metrics and filters across the US, Canada, Europe and Australia, microcaps included, with a free tier that needs no account and a one-time paid plan. Choose Stockopedia if you trust and want its composite ranks. Choose ScreenerHero if you set your own thresholds.
At a glance
| Feature | ScreenerHero | Stockopedia |
|---|---|---|
| US stocks | Strong: Yes — full coverage | Partial: US+EU plan only — €80/mo |
| Canadian stocks | Strong: Yes | Weak or absent: No |
| European stocks (incl. microcaps) | Strong: Full — all active instruments | Partial: EU plan — UK-weighted, gaps in continental EU |
| Price | Strong: Free screener, no account needed · Lifetime: 97€ once, no subscription | Weak or absent: €60/mo EU · €80/mo US+EU |
| Free tier | Strong: Yes — no account required | Weak or absent: No — 14-day trial only |
| Screener filters | Strong: P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum | Partial: StockRanks composite + limited custom filters |
| UI density | Strong: Desktop-first, data-dense tables | Partial: Card-based, narrative-oriented |
| Proprietary scoring | Partial: No composite ranks — raw data, your criteria (plus a formula-based Moat Score on quote pages) | Strong: Yes — StockRanks (Quality + Value + Momentum) |
| Heatmap | Strong: Yes — sector heatmap | Weak or absent: Limited |
| Data freshness | Partial: EOD | Partial: EOD |
Seen enough? Try it on your own criteria.
Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.
Where the differences actually matter
Coverage — US, Canadian, European & Australian microcaps
Stockopedia's European plan covers UK and Europe for €60/month but excludes the US entirely. To add US coverage, you pay €80/month — and Canada is still not included at any price point.
ScreenerHero covers US, Canada, Europe & Australia in a single plan. European coverage includes all active instruments on BME, Euronext Paris, XETRA, and Borsa Italiana — including microcaps and illiquid names that most tools skip. Where fundamental data is missing for illiquid names, it is shown explicitly rather than hidden.
Price — €80/mo subscription vs one payment
Stockopedia's US + Europe plan costs €80/month (€64/month billed annually). The Europe-only plan is €60/month. Neither includes Canada.
The ScreenerHero paid plan is a one-time Lifetime payment — no subscription, no renewal. The free tier is permanent and requires no account — you can evaluate data quality across US, Canadian, European & Australian names before paying anything.
Screener workflow — raw filters vs scored ranks
Stockopedia's core innovation is StockRanks: a composite percentile for quality, value, and momentum. It is well-built and useful if you trust the methodology and want a guided shortcut to stock ideas.
ScreenerHero exposes raw metrics — P/E, P/B, ROE, EV/EBITDA, profit margin, beta, dividend yield, and momentum — and lets you filter and sort by any combination across US, Canadian, European & Australian stocks simultaneously. If your strategy has specific thresholds, this is faster. If you prefer a guided composite score, Stockopedia is the better fit.
UI — dense data tables vs narrative cards
Stockopedia wraps data in editorial commentary and a card-based layout. This works for investors who want explanatory context alongside the numbers.
ScreenerHero is built desktop-first for analysis sessions of 30–90 minutes. The interface is dense, data-first, and optimised for speed — similar to Finviz but with global coverage. If you already know what you're looking for and want to filter a large multi-market universe fast, that design difference matters.
ScreenerHero is the better fit if…
- Investors who screen US, Canadian, European & Australian stocks in one workflow
- Anyone covering European small and microcap names most tools ignore
- Analysts who want dense, fast tables — not narrative summaries
- Users who need a serious tool without paying €80/mo before knowing if it fits
- Investors who prefer raw metrics over composite scores
Stockopedia is the better fit if…
- Investors who prefer a score-driven workflow (StockRanks)
- UK-focused investors who want editorial context alongside data
- Beginners who want a structured framework rather than raw filters
- Investors willing to pay €60–€80/mo for curated quality/value/momentum rankings
Common questions when switching
Does ScreenerHero replace Stockopedia's StockRanks?
No. There is no composite score in ScreenerHero — it is built for investors with their own criteria who want to apply those criteria to a clean dataset across US, Canadian, European & Australian markets.
Does ScreenerHero cover the same European stocks as Stockopedia?
ScreenerHero covers all active instruments on major European exchanges including BME, Euronext Paris, XETRA, and Borsa Italiana — including illiquid and microcap names. Stockopedia's European coverage is strongest in UK equities and can have gaps in continental small caps.
Can I try ScreenerHero before committing?
Yes — the screener is open without any login. Run your filters across US, Canadian, and European stocks, check coverage on the names you follow, and decide. No trial period, no time limit on the free tier.
How does the pricing model compare?
Stockopedia's annual plans are €48/mo (EU only) and €64/mo (US+EU), which is €576–768 a year, renewing every year. The ScreenerHero paid plan is a one-time Lifetime payment with no renewal — one payment against a subscription that keeps billing, for comparable global coverage.
Try ScreenerHero free — no account needed
Filter US, Canadian, European & Australian stocks by P/E, ROE, P/B, EV/EBITDA, and more. Free, no signup. Lifetime access — one payment, no subscription — when you need unlimited alerts and saved presets.
Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.